Overview

Allogeneic BM-MSCs in Patients With Lumbar Facet Arthropathy

Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
Researchers are conducting this study to learn more about the side effects of bone marrow-derived stem cells when injected into the facet joints for the treatment of painful lumbar facet joint arthropathies.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic